Viewing Study NCT06067061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-01-28 @ 3:28 AM
Study NCT ID: NCT06067061
Status: TERMINATED
Last Update Posted: 2025-06-11
First Post: 2023-09-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer
Sponsor: Institut Curie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Triple Negative Breast Cancer View
None Early-stage View
None Immunotherapy View
None Oncolytic virus View